CHIR99021 Maintenance of the Cell Stemness by Regulating Cellular Iron Metabolism.
Yingying HanYong HeXiaofang JinJiayi XiePeng YuGuofen GaoShiyang ChangJianhua ZhangYan-Zhong ChangPublished in: Antioxidants (Basel, Switzerland) (2023)
CHIR99021 is an aminopyrimidine derivative, which can efficiently inhibit the activity of glycogen synthesis kinase 3α (GSK-3α) and GSK-3β. As an essential component of stem cell culture medium, it plays an important role in maintaining cell stemness. However, the mechanism of its role is not fully understood. In the present study, we first found that removal of CHIR99021 from embryonic stem cell culture medium reduced iron storage in mouse embryonic stem cells (mESCs). CHIR99021-treated Neuro-2a cells led to an upregulation of ferritin expression and an increase in intracellular iron levels, along with GSK3β inhibition and Wnt/GSK-3β/β-catenin pathway activation. In addition, iron treatment activated the classical Wnt pathway by affecting the expression of β-catenin in the Neuro-2a cells. Our data link the role of iron in the maintenance of cell stemness via the Wnt/GSK-3β/β-catenin signaling pathway, and identify intermediate molecules, including Steap1, Bola2, and Kdm6bos, which may mediate the upregulation of ferritin expression by CHIR99021. These findings reveal novel mechanisms of the maintenance of cell stemness and differentiation and provide a theoretical basis for the development of new strategies in stem cell treatment in disease.
Keyphrases
- stem cells
- poor prognosis
- signaling pathway
- single cell
- cell proliferation
- epithelial mesenchymal transition
- cell therapy
- pi k akt
- iron deficiency
- cell cycle arrest
- embryonic stem cells
- cell death
- binding protein
- electronic health record
- gene expression
- big data
- dna methylation
- oxidative stress
- newly diagnosed
- cancer stem cells
- smoking cessation